BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17962219)

  • 1. Genetic polymorphisms in the apoptosis-associated genes FAS and FASL and breast cancer risk.
    Crew KD; Gammon MD; Terry MB; Zhang FF; Agrawal M; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM
    Carcinogenesis; 2007 Dec; 28(12):2548-51. PubMed ID: 17962219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
    Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
    Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk.
    Crew KD; Gammon MD; Terry MB; Zhang FF; Zablotska LB; Agrawal M; Shen J; Long CM; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2033-41. PubMed ID: 17932351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk.
    Terry MB; Gammon MD; Zhang FF; Eng SM; Sagiv SK; Paykin AB; Wang Q; Hayes S; Teitelbaum SL; Neugut AI; Santella RM
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2053-8. PubMed ID: 15598760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Renner W; Gerger A; Kapp KS; Langsenlehner T
    Strahlenther Onkol; 2014 Mar; 190(3):304-9. PubMed ID: 24424626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.
    Hashemi M; Fazaeli A; Ghavami S; Eskandari-Nasab E; Arbabi F; Mashhadi MA; Taheri M; Chaabane W; Jain MV; Łos MJ
    PLoS One; 2013; 8(1):e53075. PubMed ID: 23326385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.
    Park SH; Choi JE; Kim EJ; Jang JS; Lee WK; Cha SI; Kim CH; Kam S; Kim DS; Park RW; Kim YC; Han SB; Jung TH; Park JY
    Lung Cancer; 2006 Dec; 54(3):303-8. PubMed ID: 17014925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of the Fas and FasL gene polymorphisms with susceptibility to and severity of rheumatoid arthritis.
    Yıldır S; Sezgin M; Barlas IÖ; Türköz G; Ankaralı HÇ; Şahin G; Erdal ME
    Rheumatol Int; 2013 Oct; 33(10):2637-45. PubMed ID: 23749041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
    Xu Y; He B; Li R; Pan Y; Gao T; Deng Q; Sun H; Song G; Wang S
    PLoS One; 2014; 9(3):e90090. PubMed ID: 24598538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
    Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
    PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FasL -844T/C and Fas -1377G/A: mutations of pulmonary adenocarcinoma in South China and their clinical significances.
    Zhao H; Chen W; Du P; Sun A; Zhuang C; Tong J; Wang L
    Tumour Biol; 2015 Jun; 36(6):4319-26. PubMed ID: 25596086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
    Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of FAS-670A/G and FASL-844C/T polymorphisms with idiopathic azoospermia in Western Iran.
    Asgari R; Mansouri K; Bakhtiari M; Bidmeshkipour A; Yari K; Shaveisi-Zadeh F; Vaisi-Raygani A
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():55-59. PubMed ID: 28942044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis.
    Wang GQ; Bao L; Zhao XX; Zhang J; Nan KJ
    Tumour Biol; 2014 May; 35(5):4107-12. PubMed ID: 24375196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
    Shao P; Ding Q; Qin C; Wang M; Tang J; Zhu J; Chen J; Cao Q; Li J; Xu B; Zhang Z; Zhang W; Yin C
    Prostate; 2011 Jul; 71(10):1122-30. PubMed ID: 21557277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of FAS and FASL (CD95/CD95L) genes in cervical carcinogenesis: An analysis of haplotype and gene-gene interaction.
    Lai HC; Lin WY; Lin YW; Chang CC; Yu MH; Chen CC; Chu TY
    Gynecol Oncol; 2005 Oct; 99(1):113-8. PubMed ID: 15996722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAH-DNA adducts, cigarette smoking, GST polymorphisms, and breast cancer risk.
    McCarty KM; Santella RM; Steck SE; Cleveland RJ; Ahn J; Ambrosone CB; North K; Sagiv SK; Eng SM; Teitelbaum SL; Neugut AI; Gammon MD
    Environ Health Perspect; 2009 Apr; 117(4):552-8. PubMed ID: 19440493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
    Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
    Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.
    Xu Y; Deng Q; He B; Pan Y; Li R; Gao T; Sun H; Song G; Wang S; Cho WC
    Tumour Biol; 2014 Sep; 35(9):9147-61. PubMed ID: 24916571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.